(Q37592307)

21 August 2017

1 reference

title

Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C. (English)

1 reference

21 August 2017

0 references

1 reference

1 reference

1 reference

F Negro

1

1 reference

21 August 2017

S Clément

series ordinal

2

1 reference

21 August 2017

publication date

1 September 2009

1 reference

Journal of Viral Hepatitis

21 August 2017

published in

1 reference

21 August 2017

volume

16

1 reference

21 August 2017

issue

10

1 reference

21 August 2017

page(s)

681-688

1 reference

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2009.01186.X

Crossref

reference URL

High serum leptin is an independent risk factor for non-response patients with low viremia to antiviral treatment in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2009.01186.X

Crossref

reference URL

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2009.01186.X

Crossref

reference URL

10.1111/J.1365-2893.2009.01186.X

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference